BioSpace News Archive

Drug Development

Roche Withdraws Tecentriq for Bladder Cancer Indication

As the FDA cracks down on accelerated approvals, Genentech, a Roche company, voluntarily withdrew its monoclonal antibody, Tecentriq, for metastatic bladder cancer.

November 29, 2022
·
3 min read
·
Mark Terry
Deals

AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene Buyout (Updated)

AstraZeneca and Neogene have entered into a definitive acquisition agreement in which AstraZeneca will buy all outstanding equity in the smaller company.

November 29, 2022
·
2 min read
·
Tristan Manalac
Business

BMS Terminates 2015 Gene Therapy Pact with uniQure

BMS is terminating a seven-year-old gene therapy collaboration to develop potential treatments for congestive heart failure with uniQure N.V. valued at $1 billion.

November 29, 2022
·
2 min read
·
Alex Keown
Drug Development

BMS Supports $96M Launch for Neurodegenerative Newcomer Cajal (Updated)

With $96 million in Series A financing, Cajal Neuroscience launched Tuesday to develop drug candidates to target neurodegeneration in Alzheimer’s and Parkinson’s diseases.

November 29, 2022
·
2 min read
·
Rosemary Scott
Business

Merck to Leverage BigHat’s AI Platform in 3 Drug Discovery Programs

BigHat Biosciences will team up with Merck to design candidates for three drug discovery programs backed by the company’s proprietary AI technology platform.

November 29, 2022
·
2 min read
·
Alex Keown
Business

RaySearch Laboratories: Interim report July - September 2022

RaySearch announces a partnership with Leo Cancer Care in Great Britain for the development of a streamlined treatment planning solution for upright treatments.

November 29, 2022
·
2 min read
Drug Development

NETRIS Pharma Doses First Patient in Phase 2 Study of NP137 for Checkpoint Inhibitor Resistance

NETRIS Pharma, a clinical-stage private biopharmaceutical company developing a new class of drugs based on dependence receptor biology, announced dosing of the first patient in the ImmunoNET trial.

November 29, 2022
·
4 min read
BioMidwest

Steroid Injections Worsen Knee Arthritis

Two studies comparing injections commonly used to relieve the pain of knee osteoarthritis found that corticosteroid injections were associated with the progression of the disease.

November 29, 2022
·
5 min read
Biotech Bay

IDEAYA Biosciences Announces Agenda Topics and Key Opinion Leader Presenters for Investor R&D Day Webcast on Monday, December 12, 2022

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced agenda topics and participating key opinion leaders for its Investor R&D Day.

November 29, 2022
·
3 min read
Pharm Country

Zynerba Pharmaceuticals Announces Poster Presentation at the Annual Meeting of the American College of Neuropsychopharmacology

Zynerba Pharmaceuticals, Inc. today announced the presentation of a poster at the 61st Annual Meeting of the American College of Neuropsychopharmacology, being held December 4-7, 2022 in Phoenix, Ariz.

November 29, 2022
·
5 min read